Home|Journals|Articles by Year|Audio Abstracts

Original Article

J App Pharm Sci. 2017; 7(7): 186-196

A Novel Approach of Potent Antioxidant and Antimicrobial Agents Containing Coumarin Moiety Accompanied with Cytotoxicity Studies on The Newly Synthesized Derivatives

Huda R. M. Rashdan, Sami M. Nasr, Heba A. El-Refai, Mohamed S. Abdel-Aziz.


3-Amino-6-(2-oxo-2H-chromen-3-yl)pyridine-2-carbonitrile (2) was synthesized via the reaction of 3-(dimethylamino)acryloyl-2H-chromen-2-one (1) with malononitrile. The reactivity of the 2-amino-3-cyanopyridine derivative 2 toward a variety of electrophiles as triethylorthoformate followed by nitrogenous nucleophiles as hydrazine hydrate was investigated. Also, enamine 1 was utilized as precursor for synthesis of new 3-heteroarylsubstituted coumarins, in which it reacted with a series of hydrazonoyl halides and p-bromobenzenediazonium chloride to yield different3-substituted coumarins. The structures of the newly synthesized derivatives were confirmed by different spectral tools (IR, H1NMR, mass spectrometry and elemental analysis). All the newly synthesized compounds were screened for their antioxidant, antimicrobial activities and cytotoxicity. The preliminary structure-activity relationship was discussed to illustrate the essential structure requirements.

Key words: Coumarins; enamines; antioxidant agents; antimicrobial agents and cytotoxicity.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.